Is Adenomyosis hereditary?

While Adenomyosis is not considered a strictly hereditary disease caused by a single gene mutation, emerging research suggests that a genetic predisposition likely plays a role in its development.

Understanding the Genetic Component

In clinical genetics, we distinguish between hereditary conditions—which follow clear Mendelian inheritance patterns—and conditions with complex or multifactorial inheritance. Adenomyosis is currently classified as the latter. This means that instead of a single gene "causing" the disease, it likely arises from an interplay between an individual's genetic susceptibility and environmental factors, such as hormonal influences or trauma to the uterine lining.

Inheritance and Risk Factors

There is no defined inheritance pattern, such as autosomal dominant or recessive, for Adenomyosis. Consequently, we cannot provide a specific percentage risk for children of an affected parent. Because the condition is multifactorial, it does not follow the predictable patterns seen in single-gene disorders. While some studies have noted a higher prevalence of Adenomyosis among close female relatives, this may be due to a combination of shared genetic architecture and shared environmental exposures.

Genetic Testing and Counseling

Currently, there is no clinical genetic testing available to diagnose Adenomyosis or predict one’s risk of developing it. Because the underlying genetic markers remain unidentified, genetic counseling for this condition focuses on understanding family health history rather than predictive testing. If you are planning a pregnancy, counseling is valuable to discuss how the symptoms of Adenomyosis might impact fertility or pregnancy outcomes, but there is no prenatal diagnosis test for the condition itself.

De Novo Mutations and Future Research

De novo, or spontaneous, mutations are not commonly implicated in the etiology of Adenomyosis. Instead, the focus of current medical research is on the epigenetic changes that may cause the endometrial-like tissue to infiltrate the muscular wall of the uterus. As our understanding of the genomic landscape of Adenomyosis evolves, we hope to better identify the specific pathways that contribute to this challenging condition.

Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD)


• Orphanet: The portal for rare diseases and orphan drugs


• National Library of Medicine (PubMed): Systematic reviews on the pathogenesis of Adenomyosis